Cargando…

NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience

BACKGROUND AND PURPOSE: Pancreatic ductal adenocarcinoma (PDAC) remains one of the leading causes of cancer-related deaths in the world. For patients with PDAC who are not eligible for surgery, radiation therapy improves local disease control, yet safely delivering therapeutic doses of radiation rem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bagley, Alexander F., Ludmir, Ethan B., Maitra, Anirban, Minsky, Bruce D., Li Smith, Grace, Das, Prajnan, Koong, Albert C., Holliday, Emma B., Taniguchi, Cullen M., Katz, Matthew H.G., Tamm, Eric P., Wolff, Robert A., Overman, Michael J., Patel, Shivani, Kim, Michael P., Tzeng, Ching-Wei D., Ikoma, Naruhiko, Bhutani, Manoop S., Koay, Eugene J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783106/ https://www.ncbi.nlm.nih.gov/pubmed/35097226 http://dx.doi.org/10.1016/j.ctro.2021.12.012

Ejemplares similares

Patient-Reported Outcomes After Chemoradiation in Patients With Anal Cancer: A Qualitative Analysis
por: Corrigan, Kelsey L., et al.
Publicado: (2022)

Contemporary use and outcomes of radiation and chemotherapy for unresectable pancreatic cancer
por: Moningi, Shalini, et al.
Publicado: (2022)

Novel EUS-guided brachytherapy treatment of pancreatic cancer with phosphorus-32 microparticles: first United States experience
por: Bhutani, Manoop S., et al.
Publicado: (2019)

Microbubble and ultrasound radioenhancement of bladder cancer
por: Tran, W T, et al.
Publicado: (2012)

Prospects of nanoparticle-based radioenhancement for radiotherapy
por: Gerken, Lukas R. H., et al.
Publicado: (2023)

Endoscopic Ultrasound-Guided Fiducial Placement for Stereotactic Body Radiation Therapy in Patients with Pancreatic Cancer
por: Cazacu, Irina M., et al.
Publicado: (2023)

Hyperfractionated abdominal reirradiation for gastrointestinal malignancies
por: Hunt, Andrew, et al.
Publicado: (2018)

Definitive hyperfractionated, accelerated proton reirradiation for patients with pelvic malignancies
por: Moningi, Shalini, et al.
Publicado: (2019)

IMRT Reduces Acute Toxicity in Patients Treated With Preoperative Chemoradiation for Gastric Cancer
por: Moningi, Shalini, et al.
Publicado: (2019)

Permanent endoscopic reversal of Roux-en-Y gastric bypass for diagnosis and long-term palliation of pancreatic cancer
por: Hakim, Seifeldin, et al.
Publicado: (2020)

Assessment of setup uncertainty in hypofractionated liver radiation therapy with a breath-hold technique using automatic image registration–based image guidance
por: Choi, Gye Won, et al.
Publicado: (2019)

Radioenhancement with the Combination of Docetaxel and Ultrasound Microbubbles: In Vivo Prostate Cancer
por: Almasri, Firas, et al.
Publicado: (2023)

Anal cancer treatment regimen considerations for the COVID-19 era: In regard to Tchelebi et al
por: Noticewala, Sonal S., et al.
Publicado: (2020)

Mass Transport Model of Radiation Response: Calibration and Application to Chemoradiation for Pancreatic Cancer
por: Wang, Charles X., et al.
Publicado: (2022)

Impact of Fiducial Marker Placement Before Stereotactic Body Radiation Therapy on Clinical Outcomes in Patients With Pancreatic Cancer
por: Moningi, Shalini, et al.
Publicado: (2020)

Cellular fate and performance of group IV metal organic framework radioenhancers
por: Neuer, Anna Lena, et al.
Publicado: (2022)

Radiotherapy-activated NBTXR3 nanoparticles modulate cancer cell immunogenicity and TCR repertoire
por: Darmon, Audrey, et al.
Publicado: (2022)

Brain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic Analysis
por: Dodoo, Grace N, et al.
Publicado: (2023)

Implementation of a stereotactic body radiotherapy program for unresectable pancreatic cancer in an integrated community academic radiation oncology satellite network
por: Augustyn, Alexander, et al.
Publicado: (2021)

Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern Era
por: Abi Jaoude, Joseph, et al.
Publicado: (2021)

Imaging‐based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy
por: Amer, Ahmed M., et al.
Publicado: (2018)

Is it tumor encasement or arterial dissection/thrombosis? EUS to the rescue!
por: Cazacu, Irina M., et al.
Publicado: (2019)

The radioenhancement potential of Schiff base derived copper (II) compounds against lung carcinoma in vitro
por: Tsakanova, Gohar, et al.
Publicado: (2021)

Benchmarking Outcomes after Ablative Radiotherapy for Molecularly Characterized Intrahepatic Cholangiocarcinoma
por: De, Brian, et al.
Publicado: (2021)

Independent Stage Classification for Gastroesophageal Junction Adenocarcinoma
por: Hirata, Yuki, et al.
Publicado: (2023)

Imaging Features of Intratumoral Injection of NBTXR3 for Head and Neck Squamous Cell Carcinoma Lymph Node Metastases
por: Ginat, Daniel Thomas, et al.
Publicado: (2022)

3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma
por: Kang, Ya’an, et al.
Publicado: (2022)

Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma
por: Elganainy, Dalia, et al.
Publicado: (2018)

Preoperative Therapy Regimen Influences the Incidence and Implication of Nodal Downstaging in Patients with Gastric Cancer
por: Stark, Alexander P., et al.
Publicado: (2020)

Dosimetry and Radioenhancement Comparison of Gold Nanoparticles in Kilovoltage and Megavoltage Radiotherapy using MAGAT Polymer Gel Dosimeter
por: Farahani, S., et al.
Publicado: (2019)

Oncolytic Newcastle disease virus expressing a checkpoint inhibitor as a radioenhancing agent for murine melanoma
por: Vijayakumar, Gayathri, et al.
Publicado: (2019)

Outcomes and Toxicities of Modern Combined Modality Therapy with Atezolizumab Plus Bevacizumab and Radiation Therapy for Hepatocellular Carcinoma
por: Manzar, Gohar Shahwar, et al.
Publicado: (2022)

Definitive Intensity-Modulated Chemoradiation for Anal Squamous Cell Carcinoma: Outcomes and Toxicity of 428 Patients Treated at a Single Institution
por: Holliday, Emma B, et al.
Publicado: (2022)

Treatment Patterns for Gastroesophageal Junction Adenocarcinoma in the United States †
por: Kim, Bradford J., et al.
Publicado: (2020)

Staging laparoscopy and peritoneal cytology in patients with early stage gastric adenocarcinoma
por: Allen, Casey J., et al.
Publicado: (2020)

Dose escalation for locally advanced pancreatic cancer: How high can we go?
por: Colbert, Lauren E., et al.
Publicado: (2018)

Differential Spatial Gene and Protein Expression Associated with Recurrence Following Chemoradiation for Localized Anal Squamous Cell Cancer
por: Hernandez, Sharia, et al.
Publicado: (2023)

Dose Escalation for Pancreas SBRT: Potential and Limitations of using Daily Online Adaptive Radiation Therapy and an Iterative Isotoxicity Automated Planning Approach
por: Rhee, Dong Joo, et al.
Publicado: (2023)

NBTXR3 improves the efficacy of immunoradiotherapy combining nonfucosylated anti-CTLA4 in an anti-PD1 resistant lung cancer model
por: Hu, Yun, et al.
Publicado: (2022)

Comparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreatoduodenectomy
por: Liang, Tom Z., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_88t9thnp2e6n479aub0d0t6ojn